Erik Johnson, Ph. D.
My research interests focus on understanding the biochemical mechanisms that underlie Alzheimer’s disease, and developing molecular biomarkers for this disease. My graduate research training was in protein synthetic chemistry, and allowed me to become an expert in protein analysis by mass spectrometry, and with aggregating proteins and peptides such as amyloid-β that are associated with neurodegenerative disease. After completing my clinical training in general neurology, I obtained fellowship training in cognitive neurology under the mentorship of Dr. Bruce Miller at the Memory and Aging Center at UCSF while also continuing my research training as a postdoctoral fellow in Dr. Lennart Mucke’s laboratory at the Gladstone Institutes, where I studied Alzheimer’s disease using transgenic mouse models. In 2017 I joined the faculty at Emory University, where I am working on constructing proteomic networks of AD from post-mortem human and mouse brain in order to better understand the complex molecular changes that characterize this disease. I plan to use these networks to help inform our search for molecular biomarkers of AD. .